 Sean O'Leary
Concepts (411)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 106 | 2023 | 1218 | 18.600 |
Why?
| | Vaccines | 36 | 2023 | 371 | 11.320 |
Why?
| | Papillomavirus Vaccines | 31 | 2023 | 225 | 7.640 |
Why?
| | Influenza Vaccines | 37 | 2023 | 496 | 6.900 |
Why?
| | Health Knowledge, Attitudes, Practice | 37 | 2023 | 1225 | 6.240 |
Why?
| | Immunization | 24 | 2023 | 417 | 5.740 |
Why?
| | Vaccination Refusal | 14 | 2022 | 70 | 5.160 |
Why?
| | Parents | 33 | 2023 | 1255 | 5.150 |
Why?
| | Immunization Programs | 13 | 2021 | 203 | 5.050 |
Why?
| | Obstetrics | 14 | 2022 | 168 | 4.980 |
Why?
| | Gynecology | 13 | 2022 | 190 | 4.500 |
Why?
| | Motivational Interviewing | 10 | 2023 | 85 | 4.450 |
Why?
| | Patient Acceptance of Health Care | 24 | 2022 | 693 | 4.080 |
Why?
| | Influenza, Human | 20 | 2022 | 556 | 3.750 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 12 | 2022 | 89 | 3.670 |
Why?
| | Papillomavirus Infections | 18 | 2021 | 273 | 3.660 |
Why?
| | Practice Patterns, Physicians' | 24 | 2021 | 1247 | 3.450 |
Why?
| | Immunization Schedule | 20 | 2023 | 184 | 3.400 |
Why?
| | Attitude of Health Personnel | 26 | 2021 | 1011 | 3.340 |
Why?
| | Pregnancy Complications, Infectious | 8 | 2023 | 302 | 3.250 |
Why?
| | Clergy | 4 | 2020 | 15 | 2.920 |
Why?
| | Hepatitis B | 4 | 2023 | 54 | 2.460 |
Why?
| | Advisory Committees | 14 | 2023 | 220 | 2.310 |
Why?
| | Pediatrics | 16 | 2021 | 1002 | 2.240 |
Why?
| | Religion | 3 | 2020 | 73 | 2.130 |
Why?
| | Health Communication | 4 | 2021 | 48 | 2.120 |
Why?
| | Health Personnel | 12 | 2022 | 572 | 2.070 |
Why?
| | Meningococcal Vaccines | 9 | 2023 | 47 | 2.060 |
Why?
| | Whooping Cough | 6 | 2022 | 50 | 2.010 |
Why?
| | Colorado | 33 | 2021 | 4344 | 1.980 |
Why?
| | Humans | 177 | 2023 | 121869 | 1.970 |
Why?
| | Physicians, Primary Care | 11 | 2021 | 246 | 1.930 |
Why?
| | Viral Vaccines | 3 | 2020 | 95 | 1.920 |
Why?
| | Child | 61 | 2023 | 19282 | 1.920 |
Why?
| | Attitude to Health | 9 | 2020 | 417 | 1.920 |
Why?
| | Pediatricians | 8 | 2022 | 115 | 1.910 |
Why?
| | Vaccination Coverage | 7 | 2022 | 57 | 1.840 |
Why?
| | Pregnancy | 33 | 2023 | 5663 | 1.740 |
Why?
| | United States | 49 | 2023 | 13209 | 1.610 |
Why?
| | Infant | 39 | 2023 | 8440 | 1.590 |
Why?
| | Female | 105 | 2023 | 63903 | 1.550 |
Why?
| | Communication | 11 | 2023 | 755 | 1.530 |
Why?
| | Pregnant Women | 8 | 2022 | 126 | 1.510 |
Why?
| | Treatment Refusal | 5 | 2020 | 92 | 1.490 |
Why?
| | Social Media | 4 | 2021 | 161 | 1.470 |
Why?
| | Primary Health Care | 13 | 2021 | 1619 | 1.340 |
Why?
| | Health Promotion | 5 | 2020 | 711 | 1.340 |
Why?
| | Adolescent Health Services | 4 | 2015 | 67 | 1.320 |
Why?
| | Adult | 62 | 2022 | 32683 | 1.310 |
Why?
| | Physicians, Family | 10 | 2021 | 239 | 1.270 |
Why?
| | Adolescent | 48 | 2022 | 19126 | 1.240 |
Why?
| | Surveys and Questionnaires | 31 | 2022 | 4922 | 1.230 |
Why?
| | Measles | 4 | 2022 | 37 | 1.180 |
Why?
| | Prenatal Care | 2 | 2020 | 251 | 1.160 |
Why?
| | Physicians | 11 | 2022 | 791 | 1.130 |
Why?
| | Infectious Disease Transmission, Vertical | 4 | 2023 | 157 | 1.120 |
Why?
| | Diphtheria | 4 | 2022 | 20 | 1.100 |
Why?
| | Measles-Mumps-Rubella Vaccine | 3 | 2022 | 42 | 1.090 |
Why?
| | Tetanus | 4 | 2022 | 26 | 1.090 |
Why?
| | Patient Outcome Assessment | 2 | 2019 | 135 | 1.070 |
Why?
| | Policy | 3 | 2020 | 130 | 1.040 |
Why?
| | Health Care Surveys | 12 | 2021 | 564 | 1.020 |
Why?
| | Child, Preschool | 25 | 2023 | 9776 | 0.970 |
Why?
| | Ambulatory Care | 4 | 2020 | 495 | 0.950 |
Why?
| | Practice Guidelines as Topic | 11 | 2023 | 1511 | 0.950 |
Why?
| | Male | 70 | 2021 | 60475 | 0.930 |
Why?
| | Physician-Patient Relations | 5 | 2020 | 512 | 0.900 |
Why?
| | Religion and Medicine | 2 | 2019 | 29 | 0.900 |
Why?
| | Reminder Systems | 4 | 2019 | 164 | 0.880 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 4 | 2022 | 138 | 0.860 |
Why?
| | Hepatitis B Vaccines | 4 | 2023 | 48 | 0.840 |
Why?
| | Trust | 2 | 2020 | 110 | 0.830 |
Why?
| | Arthritis, Infectious | 1 | 2022 | 51 | 0.830 |
Why?
| | Health Services Research | 4 | 2019 | 379 | 0.830 |
Why?
| | Refusal to Treat | 2 | 2020 | 22 | 0.830 |
Why?
| | Herpes Zoster Vaccine | 6 | 2022 | 158 | 0.800 |
Why?
| | Private Practice | 1 | 2020 | 29 | 0.790 |
Why?
| | Standing Orders | 2 | 2020 | 11 | 0.790 |
Why?
| | Infant, Newborn | 14 | 2023 | 5336 | 0.780 |
Why?
| | Preventive Health Services | 2 | 2020 | 142 | 0.770 |
Why?
| | Professional-Patient Relations | 3 | 2018 | 146 | 0.770 |
Why?
| | Osteomyelitis | 1 | 2022 | 111 | 0.770 |
Why?
| | Pneumococcal Vaccines | 6 | 2021 | 140 | 0.770 |
Why?
| | Pandemics | 4 | 2023 | 1316 | 0.760 |
Why?
| | Myocarditis | 1 | 2021 | 96 | 0.750 |
Why?
| | Anti-Vaccination Movement | 1 | 2019 | 4 | 0.750 |
Why?
| | Stakeholder Participation | 1 | 2020 | 68 | 0.740 |
Why?
| | Freedom | 1 | 2019 | 12 | 0.730 |
Why?
| | Down Syndrome | 2 | 2021 | 361 | 0.730 |
Why?
| | Middle Aged | 37 | 2021 | 28961 | 0.730 |
Why?
| | Community Participation | 1 | 2020 | 126 | 0.730 |
Why?
| | Text Messaging | 3 | 2019 | 162 | 0.730 |
Why?
| | Cross-Sectional Studies | 11 | 2022 | 4713 | 0.730 |
Why?
| | Health Care Costs | 3 | 2020 | 411 | 0.720 |
Why?
| | Safety-net Providers | 1 | 2021 | 110 | 0.720 |
Why?
| | Chickenpox Vaccine | 3 | 2017 | 70 | 0.700 |
Why?
| | Disease Outbreaks | 3 | 2022 | 330 | 0.700 |
Why?
| | Schools | 2 | 2019 | 426 | 0.690 |
Why?
| | Young Adult | 20 | 2020 | 11223 | 0.680 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2020 | 145 | 0.670 |
Why?
| | Information Seeking Behavior | 1 | 2018 | 31 | 0.660 |
Why?
| | Rotavirus Vaccines | 2 | 2021 | 48 | 0.650 |
Why?
| | Rotavirus Infections | 2 | 2021 | 55 | 0.650 |
Why?
| | Mothers | 5 | 2022 | 707 | 0.650 |
Why?
| | Patient Preference | 2 | 2017 | 172 | 0.640 |
Why?
| | Documentation | 2 | 2019 | 181 | 0.640 |
Why?
| | Hepatitis A Vaccines | 4 | 2019 | 16 | 0.630 |
Why?
| | Urban Population | 3 | 2020 | 433 | 0.630 |
Why?
| | Public Health | 2 | 2020 | 470 | 0.620 |
Why?
| | Rural Population | 4 | 2021 | 486 | 0.620 |
Why?
| | Cues | 1 | 2019 | 314 | 0.610 |
Why?
| | Mass Media | 1 | 2016 | 37 | 0.590 |
Why?
| | Mumps | 3 | 2022 | 20 | 0.580 |
Why?
| | Physician's Role | 2 | 2019 | 210 | 0.580 |
Why?
| | Health Education | 2 | 2018 | 328 | 0.580 |
Why?
| | School Health Services | 3 | 2015 | 205 | 0.560 |
Why?
| | Delivery of Health Care | 3 | 2023 | 855 | 0.540 |
Why?
| | Vaccines, Combined | 4 | 2023 | 47 | 0.540 |
Why?
| | Healthcare Disparities | 1 | 2021 | 492 | 0.530 |
Why?
| | Computers, Handheld | 1 | 2015 | 25 | 0.530 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2018 | 214 | 0.530 |
Why?
| | Dengue Vaccines | 3 | 2019 | 9 | 0.510 |
Why?
| | Anthrax Vaccines | 3 | 2018 | 6 | 0.510 |
Why?
| | Streptococcal Vaccines | 1 | 2014 | 6 | 0.510 |
Why?
| | Hepatitis B Surface Antigens | 2 | 2023 | 19 | 0.480 |
Why?
| | Recovery of Function | 2 | 2020 | 612 | 0.480 |
Why?
| | Qualitative Research | 6 | 2020 | 891 | 0.460 |
Why?
| | Seizures, Febrile | 1 | 2012 | 19 | 0.450 |
Why?
| | Patient-Centered Care | 2 | 2015 | 509 | 0.440 |
Why?
| | Internet | 5 | 2019 | 698 | 0.440 |
Why?
| | Respiratory Syncytial Virus Vaccines | 3 | 2023 | 24 | 0.440 |
Why?
| | Meningococcal Infections | 3 | 2018 | 22 | 0.440 |
Why?
| | Nurseries, Hospital | 1 | 2012 | 4 | 0.440 |
Why?
| | Safety | 2 | 2020 | 313 | 0.440 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 1 | 2012 | 14 | 0.430 |
Why?
| | Georgia | 6 | 2021 | 62 | 0.430 |
Why?
| | Herpes Zoster | 3 | 2022 | 325 | 0.430 |
Why?
| | Streptococcal Infections | 1 | 2014 | 141 | 0.430 |
Why?
| | Age Factors | 6 | 2021 | 3173 | 0.410 |
Why?
| | Skin Diseases, Bacterial | 3 | 2016 | 26 | 0.400 |
Why?
| | Rotator Cuff | 3 | 2009 | 49 | 0.390 |
Why?
| | Family Practice | 7 | 2017 | 486 | 0.390 |
Why?
| | Mumps Vaccine | 3 | 2021 | 15 | 0.390 |
Why?
| | Pertussis Vaccine | 3 | 2022 | 24 | 0.390 |
Why?
| | Evidence-Based Medicine | 4 | 2020 | 739 | 0.370 |
Why?
| | Respiratory Syncytial Virus Infections | 2 | 2023 | 103 | 0.370 |
Why?
| | Attitude | 3 | 2021 | 242 | 0.360 |
Why?
| | Tenodesis | 1 | 2009 | 22 | 0.360 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2020 | 1254 | 0.350 |
Why?
| | Japanese Encephalitis Vaccines | 2 | 2018 | 2 | 0.350 |
Why?
| | Anterior Cruciate Ligament Injuries | 2 | 2022 | 147 | 0.350 |
Why?
| | Vaccines, Contraceptive | 1 | 2008 | 1 | 0.340 |
Why?
| | Egg Proteins | 1 | 2008 | 19 | 0.340 |
Why?
| | Hepatitis B virus | 2 | 2023 | 25 | 0.340 |
Why?
| | Ovulation | 1 | 2008 | 41 | 0.340 |
Why?
| | Health Policy | 1 | 2012 | 356 | 0.340 |
Why?
| | Tendon Injuries | 1 | 2009 | 78 | 0.340 |
Why?
| | Retrospective Studies | 12 | 2023 | 13063 | 0.330 |
Why?
| | Aged | 16 | 2021 | 20705 | 0.330 |
Why?
| | Ovarian Follicle | 1 | 2008 | 60 | 0.330 |
Why?
| | Guideline Adherence | 2 | 2013 | 552 | 0.320 |
Why?
| | Cytomegalovirus | 1 | 2008 | 140 | 0.310 |
Why?
| | Maternal Health Services | 2 | 2019 | 79 | 0.310 |
Why?
| | Child Health | 2 | 2019 | 124 | 0.310 |
Why?
| | Societies, Medical | 4 | 2019 | 744 | 0.310 |
Why?
| | Mobile Applications | 2 | 2020 | 156 | 0.300 |
Why?
| | Professional-Family Relations | 3 | 2018 | 136 | 0.300 |
Why?
| | Respiratory Syncytial Viruses | 2 | 2023 | 50 | 0.300 |
Why?
| | Vaccines, Synthetic | 3 | 2022 | 127 | 0.300 |
Why?
| | Cost-Benefit Analysis | 2 | 2020 | 560 | 0.290 |
Why?
| | Receptors, Cell Surface | 1 | 2008 | 368 | 0.290 |
Why?
| | Logistic Models | 3 | 2021 | 2037 | 0.290 |
Why?
| | Membrane Glycoproteins | 1 | 2008 | 450 | 0.280 |
Why?
| | Data Collection | 3 | 2014 | 677 | 0.280 |
Why?
| | Shoulder Joint | 2 | 2008 | 171 | 0.270 |
Why?
| | Seasons | 2 | 2020 | 469 | 0.250 |
Why?
| | Time Factors | 4 | 2020 | 6889 | 0.250 |
Why?
| | Patient Education as Topic | 2 | 2019 | 720 | 0.240 |
Why?
| | Blood Coagulation Tests | 1 | 2023 | 67 | 0.240 |
Why?
| | Decision Making | 3 | 2020 | 825 | 0.240 |
Why?
| | Hospitals | 3 | 2023 | 598 | 0.220 |
Why?
| | Gout | 1 | 2003 | 57 | 0.220 |
Why?
| | Rubella | 1 | 2022 | 15 | 0.220 |
Why?
| | Infant Health | 1 | 2022 | 15 | 0.220 |
Why?
| | Neisseria meningitidis, Serogroup B | 2 | 2018 | 15 | 0.210 |
Why?
| | Intention | 2 | 2020 | 152 | 0.210 |
Why?
| | Hospitalization | 7 | 2023 | 1873 | 0.210 |
Why?
| | Russia | 1 | 2021 | 10 | 0.210 |
Why?
| | Germany | 1 | 2021 | 89 | 0.200 |
Why?
| | Complementary Therapies | 1 | 2022 | 71 | 0.200 |
Why?
| | Yellow Fever Vaccine | 2 | 2017 | 6 | 0.200 |
Why?
| | Knee Injuries | 1 | 2022 | 104 | 0.200 |
Why?
| | General Practitioners | 1 | 2021 | 21 | 0.200 |
Why?
| | Anti-Bacterial Agents | 3 | 2016 | 1491 | 0.200 |
Why?
| | Hospital Rapid Response Team | 1 | 2021 | 18 | 0.200 |
Why?
| | Clinical Competence | 2 | 2018 | 957 | 0.200 |
Why?
| | Internal Medicine | 2 | 2014 | 223 | 0.200 |
Why?
| | Regression Analysis | 2 | 2020 | 1049 | 0.190 |
Why?
| | Risk | 2 | 2015 | 925 | 0.190 |
Why?
| | Cluster Analysis | 2 | 2022 | 512 | 0.190 |
Why?
| | Antiviral Agents | 2 | 2023 | 673 | 0.190 |
Why?
| | Washington | 1 | 2020 | 137 | 0.190 |
Why?
| | Measles Vaccine | 1 | 2019 | 19 | 0.190 |
Why?
| | Aged, 80 and over | 5 | 2020 | 6974 | 0.190 |
Why?
| | Drug Storage | 1 | 2020 | 63 | 0.190 |
Why?
| | Norovirus | 1 | 2020 | 26 | 0.190 |
Why?
| | Eligibility Determination | 1 | 2020 | 54 | 0.180 |
Why?
| | Fever | 1 | 2021 | 291 | 0.180 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2020 | 82 | 0.180 |
Why?
| | Pennsylvania | 1 | 2019 | 96 | 0.180 |
Why?
| | Reimbursement Mechanisms | 1 | 2020 | 81 | 0.180 |
Why?
| | State Government | 1 | 2019 | 43 | 0.180 |
Why?
| | Medicaid | 2 | 2021 | 409 | 0.180 |
Why?
| | Government Regulation | 1 | 2019 | 49 | 0.180 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2017 | 89 | 0.180 |
Why?
| | Gastroenteritis | 1 | 2020 | 64 | 0.180 |
Why?
| | Europe | 1 | 2020 | 368 | 0.170 |
Why?
| | Therapeutic Uses | 1 | 2018 | 1 | 0.170 |
Why?
| | Morbidity | 1 | 2020 | 300 | 0.170 |
Why?
| | Community-Based Participatory Research | 1 | 2019 | 133 | 0.170 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 387 | 0.170 |
Why?
| | Urban Health Services | 1 | 2018 | 67 | 0.170 |
Why?
| | Education, Continuing | 1 | 2018 | 42 | 0.160 |
Why?
| | Evidence-Based Practice | 2 | 2020 | 185 | 0.160 |
Why?
| | Nuclear Family | 1 | 2018 | 54 | 0.160 |
Why?
| | Quality Improvement | 3 | 2020 | 996 | 0.160 |
Why?
| | Rural Health Services | 1 | 2018 | 109 | 0.160 |
Why?
| | Guatemala | 4 | 2020 | 299 | 0.160 |
Why?
| | Altitude | 1 | 2021 | 441 | 0.160 |
Why?
| | Ambulatory Care Facilities | 2 | 2019 | 237 | 0.160 |
Why?
| | Cervical Plexus | 1 | 1997 | 1 | 0.150 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2017 | 69 | 0.150 |
Why?
| | Hemorrhage | 1 | 2021 | 647 | 0.150 |
Why?
| | Spinal Nerve Roots | 1 | 1997 | 30 | 0.150 |
Why?
| | Pneumococcal Infections | 1 | 2018 | 96 | 0.150 |
Why?
| | Travel | 1 | 2017 | 118 | 0.150 |
Why?
| | Adaptation, Psychological | 2 | 2020 | 589 | 0.150 |
Why?
| | Administrative Personnel | 1 | 2016 | 35 | 0.150 |
Why?
| | Focus Groups | 5 | 2018 | 382 | 0.150 |
Why?
| | Physician Executives | 1 | 2016 | 36 | 0.150 |
Why?
| | Cost of Illness | 2 | 2018 | 286 | 0.150 |
Why?
| | Allied Health Personnel | 1 | 2016 | 46 | 0.150 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1574 | 0.140 |
Why?
| | Vaccines, Conjugate | 2 | 2018 | 61 | 0.140 |
Why?
| | Curriculum | 1 | 2023 | 898 | 0.140 |
Why?
| | Public Health Practice | 1 | 2016 | 58 | 0.140 |
Why?
| | Mass Screening | 1 | 2023 | 1089 | 0.140 |
Why?
| | Zika Virus Infection | 1 | 2017 | 84 | 0.140 |
Why?
| | Behavior Therapy | 1 | 2019 | 260 | 0.140 |
Why?
| | Diphtheria Toxoid | 1 | 2015 | 14 | 0.140 |
Why?
| | Leadership | 1 | 2019 | 317 | 0.140 |
Why?
| | Postpartum Period | 1 | 2018 | 264 | 0.140 |
Why?
| | Tetanus Toxoid | 1 | 2015 | 41 | 0.140 |
Why?
| | Demography | 1 | 2017 | 286 | 0.140 |
Why?
| | Patient Participation | 1 | 2019 | 371 | 0.140 |
Why?
| | Incidence | 2 | 2020 | 2520 | 0.140 |
Why?
| | Minority Groups | 1 | 2018 | 248 | 0.140 |
Why?
| | Intention to Treat Analysis | 1 | 2015 | 71 | 0.140 |
Why?
| | Equipment and Supplies | 1 | 2015 | 41 | 0.140 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2017 | 170 | 0.140 |
Why?
| | Cooperative Behavior | 3 | 2014 | 414 | 0.140 |
Why?
| | Herpesvirus 3, Human | 1 | 2019 | 382 | 0.130 |
Why?
| | California | 1 | 2016 | 386 | 0.130 |
Why?
| | Information Dissemination | 1 | 2017 | 220 | 0.130 |
Why?
| | Neck Pain | 1 | 2014 | 22 | 0.130 |
Why?
| | Occupational Health Services | 1 | 2014 | 34 | 0.130 |
Why?
| | Prevalence | 1 | 2021 | 2444 | 0.130 |
Why?
| | Anterior Cruciate Ligament | 1 | 2015 | 89 | 0.130 |
Why?
| | Nurses | 1 | 2016 | 135 | 0.130 |
Why?
| | Lung Diseases | 1 | 2021 | 759 | 0.130 |
Why?
| | Prospective Studies | 3 | 2021 | 6629 | 0.120 |
Why?
| | Poverty | 1 | 2018 | 475 | 0.120 |
Why?
| | Public Health Administration | 1 | 2014 | 79 | 0.120 |
Why?
| | Circovirus | 1 | 2013 | 7 | 0.120 |
Why?
| | Sexual Behavior | 1 | 2018 | 483 | 0.120 |
Why?
| | Clinical Decision-Making | 3 | 2021 | 287 | 0.120 |
Why?
| | Intussusception | 1 | 2013 | 27 | 0.110 |
Why?
| | Adolescent Behavior | 1 | 2018 | 502 | 0.110 |
Why?
| | Drug Contamination | 1 | 2013 | 61 | 0.110 |
Why?
| | Workplace | 1 | 2014 | 241 | 0.110 |
Why?
| | Social Behavior | 1 | 2015 | 306 | 0.110 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2013 | 70 | 0.110 |
Why?
| | Parent-Child Relations | 1 | 2015 | 250 | 0.110 |
Why?
| | Health Services Accessibility | 1 | 2019 | 816 | 0.110 |
Why?
| | Electronic Health Records | 1 | 2019 | 821 | 0.110 |
Why?
| | Follow-Up Studies | 3 | 2020 | 4883 | 0.110 |
Why?
| | Neisseria meningitidis | 1 | 2011 | 20 | 0.110 |
Why?
| | Outpatients | 1 | 2015 | 335 | 0.110 |
Why?
| | Professional Practice Location | 1 | 2011 | 32 | 0.110 |
Why?
| | Perinatal Care | 1 | 2012 | 41 | 0.110 |
Why?
| | Patient Compliance | 1 | 2016 | 569 | 0.110 |
Why?
| | Community-Institutional Relations | 1 | 2012 | 94 | 0.100 |
Why?
| | Risk Factors | 4 | 2023 | 9419 | 0.100 |
Why?
| | United Kingdom | 3 | 2020 | 254 | 0.100 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2010 | 40 | 0.100 |
Why?
| | Sports | 1 | 2012 | 191 | 0.090 |
Why?
| | Hospices | 1 | 2011 | 67 | 0.090 |
Why?
| | Pain Measurement | 1 | 2012 | 484 | 0.090 |
Why?
| | Swine | 1 | 2013 | 777 | 0.090 |
Why?
| | Cognition | 1 | 2018 | 1083 | 0.090 |
Why?
| | Activities of Daily Living | 1 | 2012 | 378 | 0.090 |
Why?
| | Neuromuscular Diseases | 1 | 2011 | 92 | 0.090 |
Why?
| | Communicable Diseases | 2 | 2022 | 132 | 0.090 |
Why?
| | Rotator Cuff Injuries | 1 | 2009 | 59 | 0.090 |
Why?
| | Zona Pellucida Glycoproteins | 1 | 2008 | 2 | 0.090 |
Why?
| | Growth Differentiation Factor 9 | 1 | 2008 | 4 | 0.090 |
Why?
| | Connexin 43 | 1 | 2008 | 26 | 0.080 |
Why?
| | Infertility, Female | 1 | 2008 | 96 | 0.080 |
Why?
| | Appointments and Schedules | 2 | 2019 | 81 | 0.080 |
Why?
| | Embryonic Development | 1 | 2008 | 130 | 0.080 |
Why?
| | Leukocytes | 1 | 2008 | 291 | 0.080 |
Why?
| | Registries | 1 | 2015 | 1956 | 0.080 |
Why?
| | Cell Phone | 2 | 2019 | 83 | 0.070 |
Why?
| | Ovary | 1 | 2008 | 213 | 0.070 |
Why?
| | Tendons | 1 | 2008 | 133 | 0.070 |
Why?
| | Quality of Life | 2 | 2020 | 2453 | 0.070 |
Why?
| | Health Surveys | 2 | 2018 | 478 | 0.070 |
Why?
| | Fetal Development | 1 | 2008 | 250 | 0.070 |
Why?
| | Mice, Inbred BALB C | 1 | 2008 | 1237 | 0.070 |
Why?
| | Cohort Studies | 2 | 2014 | 5300 | 0.070 |
Why?
| | Immobilization | 1 | 2004 | 45 | 0.060 |
Why?
| | Homeodomain Proteins | 1 | 2008 | 490 | 0.060 |
Why?
| | Algorithms | 2 | 2023 | 1618 | 0.060 |
Why?
| | Treatment Outcome | 4 | 2022 | 9654 | 0.060 |
Why?
| | Shoulder Dislocation | 1 | 2004 | 52 | 0.060 |
Why?
| | Neoplasms | 1 | 2018 | 2241 | 0.060 |
Why?
| | Palivizumab | 1 | 2023 | 13 | 0.060 |
Why?
| | Acromion | 1 | 2003 | 9 | 0.060 |
Why?
| | State Medicine | 1 | 2022 | 22 | 0.060 |
Why?
| | Arthroplasty | 1 | 2003 | 52 | 0.060 |
Why?
| | Health Services | 1 | 2023 | 114 | 0.050 |
Why?
| | Sensitivity and Specificity | 2 | 2023 | 1871 | 0.050 |
Why?
| | Psychiatric Nursing | 1 | 2001 | 6 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2012 | 2322 | 0.050 |
Why?
| | Dissociative Disorders | 1 | 2001 | 25 | 0.050 |
Why?
| | Cadaver | 2 | 2004 | 321 | 0.050 |
Why?
| | Vaccines, Inactivated | 1 | 2021 | 67 | 0.050 |
Why?
| | Nurse-Patient Relations | 1 | 2001 | 47 | 0.050 |
Why?
| | Vaccines, Attenuated | 1 | 2021 | 115 | 0.050 |
Why?
| | Hip Prosthesis | 1 | 2000 | 37 | 0.050 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2020 | 46 | 0.050 |
Why?
| | Transcription Factors | 1 | 2008 | 1629 | 0.050 |
Why?
| | Social Networking | 1 | 2020 | 36 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2020 | 244 | 0.040 |
Why?
| | Maternal Age | 1 | 2019 | 125 | 0.040 |
Why?
| | Knee Joint | 1 | 2022 | 361 | 0.040 |
Why?
| | Nursing Staff, Hospital | 1 | 2001 | 145 | 0.040 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2023 | 660 | 0.040 |
Why?
| | Animals | 2 | 2013 | 34134 | 0.040 |
Why?
| | Serogroup | 1 | 2018 | 31 | 0.040 |
Why?
| | Ultrasonography | 1 | 2003 | 736 | 0.040 |
Why?
| | Pharmacists | 1 | 2021 | 246 | 0.040 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2018 | 61 | 0.040 |
Why?
| | Awareness | 1 | 2018 | 96 | 0.040 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2017 | 29 | 0.040 |
Why?
| | Patients | 1 | 2018 | 138 | 0.040 |
Why?
| | Databases, Factual | 1 | 2023 | 1285 | 0.040 |
Why?
| | Accessory Nerve | 1 | 1997 | 3 | 0.040 |
Why?
| | Educational Status | 1 | 2019 | 445 | 0.040 |
Why?
| | Nurse Practitioners | 1 | 2018 | 109 | 0.040 |
Why?
| | Interviews as Topic | 1 | 2019 | 604 | 0.040 |
Why?
| | Health Plan Implementation | 1 | 2018 | 128 | 0.040 |
Why?
| | Risk Assessment | 3 | 2015 | 3248 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2017 | 207 | 0.040 |
Why?
| | Insurance Coverage | 1 | 2018 | 217 | 0.040 |
Why?
| | Self Report | 1 | 2020 | 740 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2019 | 618 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1472 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1383 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 343 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2019 | 595 | 0.030 |
Why?
| | Ergonomics | 1 | 2014 | 24 | 0.030 |
Why?
| | Decision Support Techniques | 1 | 2018 | 394 | 0.030 |
Why?
| | Prescriptions | 1 | 2014 | 61 | 0.030 |
Why?
| | Wound Infection | 1 | 2014 | 31 | 0.030 |
Why?
| | Efficiency | 1 | 2014 | 91 | 0.030 |
Why?
| | Abscess | 1 | 2014 | 78 | 0.030 |
Why?
| | Occupational Injuries | 1 | 2014 | 57 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2652 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 1898 | 0.030 |
Why?
| | Program Evaluation | 1 | 2018 | 876 | 0.030 |
Why?
| | Medically Uninsured | 1 | 2014 | 132 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2014 | 201 | 0.030 |
Why?
| | Mice | 1 | 2008 | 15621 | 0.030 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 12 | 0.030 |
Why?
| | Pharmaceutical Services | 1 | 2011 | 79 | 0.020 |
Why?
| | Acute Disease | 2 | 2004 | 986 | 0.020 |
Why?
| | Biomechanical Phenomena | 2 | 2004 | 689 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2014 | 680 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2876 | 0.020 |
Why?
| | Orthopedic Procedures | 1 | 2008 | 219 | 0.020 |
Why?
| | Palliative Care | 1 | 2011 | 613 | 0.020 |
Why?
| | Rotation | 1 | 2004 | 126 | 0.020 |
Why?
| | Posture | 1 | 2004 | 172 | 0.010 |
Why?
| | Exercise | 1 | 2014 | 1866 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2010 | 3314 | 0.010 |
Why?
| | Range of Motion, Articular | 1 | 2004 | 374 | 0.010 |
Why?
| | Machiavellianism | 1 | 2001 | 2 | 0.010 |
Why?
| | Helping Behavior | 1 | 2001 | 14 | 0.010 |
Why?
| | Nursing Methodology Research | 1 | 2001 | 48 | 0.010 |
Why?
| | Chromium Alloys | 1 | 2000 | 5 | 0.010 |
Why?
| | Durapatite | 1 | 2000 | 54 | 0.010 |
Why?
| | Porosity | 1 | 2000 | 89 | 0.010 |
Why?
| | Psychological Theory | 1 | 2001 | 100 | 0.010 |
Why?
| | Bone Cements | 1 | 2000 | 39 | 0.010 |
Why?
| | Coated Materials, Biocompatible | 1 | 2000 | 64 | 0.010 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2000 | 107 | 0.010 |
Why?
| | Prosthesis Design | 1 | 2000 | 286 | 0.010 |
Why?
| | Reoperation | 1 | 2000 | 578 | 0.010 |
Why?
| | Social Support | 1 | 2001 | 558 | 0.010 |
Why?
| | Survival Analysis | 1 | 2000 | 1356 | 0.010 |
Why?
|
|
O'Leary's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|